Portfolio Holdings Detail for ISIN IE0007O06KL9
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares Russell 2000 Swap UCITS ETF
IssuerBlackrock
ETF TickerRU2K.AS(USD) CXE
ETF TickerRU2K(USD) Euronext Amsterdam

Holdings detail for NTRA

Stock NameNatera Inc
TickerNTRA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS6323071042

Show aggregate NTRA holdings

News associated with NTRA

Financial Contrast: Natera (NASDAQ:NTRA) & Oncology Institute (NASDAQ:TOI)
Natera (NASDAQ:NTRA – Get Free Report) and Oncology Institute (NASDAQ:TOI – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation. Institutional and Insider Ownership 99.9% of Natera shares are […] - 2025-09-17 03:14:43
Natera (NASDAQ:NTRA) Stock Acquired Rep. Josh Gottheimer
Representative Josh Gottheimer (D-New Jersey) recently bought shares of Natera, Inc. (NASDAQ:NTRA). In a filing disclosed on September 05th, the Representative disclosed that they had bought between $1,001 and $15,000 in Natera stock on August 22nd. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account. Representative Josh Gottheimer also […] - 2025-09-09 03:10:46
Natera, Inc. (NASDAQ:NTRA) Receives $194.00 Average Price Target from Brokerages
Natera, Inc. (NASDAQ:NTRA – Get Free Report) has earned a consensus rating of “Buy” from the eighteen ratings firms that are covering the firm, Marketbeat Ratings reports. Seventeen research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target […] - 2025-09-08 03:08:53
Rowan Chapman Sells 2,750 Shares of Natera (NASDAQ:NTRA) Stock
Natera, Inc. (NASDAQ:NTRA – Get Free Report) Director Rowan Chapman sold 2,750 shares of the firm’s stock in a transaction that occurred on Thursday, August 28th. The stock was sold at an average price of $166.99, for a total value of $459,222.50. Following the completion of the sale, the director directly owned 6,015 shares in […] - 2025-09-04 05:23:03
Financial Survey: Natera (NASDAQ:NTRA) vs. Solventum (NYSE:SOLV)
Natera (NASDAQ:NTRA – Get Free Report) and Solventum (NYSE:SOLV – Get Free Report) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Analyst Recommendations This is a summary of current ratings […] - 2025-08-15 05:40:53
Natera, Inc. (NASDAQ:NTRA) Receives $192.53 Consensus Target Price from Analysts
Natera, Inc. (NASDAQ:NTRA – Get Free Report) has earned an average recommendation of “Buy” from the seventeen ratings firms that are covering the company, MarketBeat reports. Sixteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among analysts […] - 2025-08-14 03:07:06
Deutsche Bank AG Purchases 160,243 Shares of Natera, Inc. (NASDAQ:NTRA)
Deutsche Bank AG raised its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 185.8% in the first quarter, HoldingsChannel reports. The firm owned 246,482 shares of the medical research company’s stock after acquiring an additional 160,243 shares during the period. Deutsche Bank AG’s holdings in Natera were worth $34,855,000 as of its […] - 2025-08-13 05:24:57
Charles Schwab Investment Management Inc. Raises Holdings in Natera, Inc. (NASDAQ:NTRA)
Charles Schwab Investment Management Inc. boosted its stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 4.4% in the 1st quarter, HoldingsChannel reports. The fund owned 905,676 shares of the medical research company’s stock after buying an additional 38,180 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Natera were worth […] - 2025-08-12 05:23:02
NTRA Makes Bullish Cross Above Critical Moving Average
In trading on Friday, shares of Natera Inc (Symbol: NTRA) crossed above their 200 day moving average of $154.62, changing hands as high as $165.09 per share. Natera Inc shares are currently trading up about 11.7% on the day. The chart below shows the one year performance of NT - 2025-08-08 12:49:35
Harbour Investments Inc. Has $139,000 Stock Position in Natera, Inc. (NASDAQ:NTRA)
Harbour Investments Inc. raised its holdings in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 57.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 983 shares of the medical research company’s stock after buying an additional 359 shares […] - 2025-08-08 05:26:55
Natera, Inc. (NASDAQ:NTRA) Shares Purchased by HighPoint Advisor Group LLC
HighPoint Advisor Group LLC lifted its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 30.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,986 shares of the medical research company’s stock after purchasing an additional 468 shares during […] - 2025-07-24 08:19:53
Solomon Moshkevich Sells 1,649 Shares of Natera, Inc. (NASDAQ:NTRA) Stock
Natera, Inc. (NASDAQ:NTRA – Get Free Report) insider Solomon Moshkevich sold 1,649 shares of the stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $156.85, for a total transaction of $258,645.65. Following the completion of the sale, the insider owned 128,556 shares of the company’s stock, valued […] - 2025-07-24 06:20:52
Notable Two Hundred Day Moving Average Cross - NTRA
In trading on Tuesday, shares of Natera Inc (Symbol: NTRA) crossed below their 200 day moving average of $153.49, changing hands as low as $152.02 per share. Natera Inc shares are currently trading off about 3.6% on the day. The chart below shows the one year performance of NT - 2025-07-15 12:33:44
Cerity Partners LLC Has $12.11 Million Stock Position in Natera, Inc. (NASDAQ:NTRA)
Cerity Partners LLC raised its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 7.3% in the first quarter, HoldingsChannel.com reports. The firm owned 85,645 shares of the medical research company’s stock after purchasing an additional 5,863 shares during the quarter. Cerity Partners LLC’s holdings in Natera were worth $12,111,000 at the end […] - 2025-07-15 07:46:49
Oppenheimer Asset Management Inc. Trims Holdings in Natera, Inc. (NASDAQ:NTRA)
Oppenheimer Asset Management Inc. decreased its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 12.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 17,744 shares of the medical research company’s stock after selling 2,515 shares during the period. […] - 2025-06-27 05:38:46
Analysts Anticipate 10% Upside For TGRT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-26 12:59:13
ORG Partners LLC Purchases Shares of 233 Natera, Inc. (NASDAQ:NTRA)
ORG Partners LLC bought a new position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) during the first quarter, HoldingsChannel.com reports. The firm bought 233 shares of the medical research company’s stock, valued at approximately $32,000. A number of other institutional investors and hedge funds have also recently made changes to their positions in […] - 2025-06-23 05:08:59
Exchange Traded Concepts LLC Buys 871 Shares of Natera, Inc. (NASDAQ:NTRA)
Exchange Traded Concepts LLC increased its holdings in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 15.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,458 shares of the medical research company’s stock after buying an additional 871 shares during […] - 2025-06-20 05:49:06
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Fifth Third Bancorp
Fifth Third Bancorp cut its stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 81.1% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,064 shares of the medical research company’s stock after selling 4,565 shares during the period. Fifth Third Bancorp’s holdings […] - 2025-06-20 04:46:49
XBI, EXAS, NBIX, NTRA: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $443.9 million dollar outflow -- that's a 8.8% decrease week over week - 2025-06-17 11:54:37
Wedmont Private Capital Buys Shares of 1,506 Natera, Inc. (NASDAQ:NTRA)
Wedmont Private Capital purchased a new position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,506 shares of the medical research company’s stock, valued at approximately $223,000. A number of other institutional investors have also […] - 2025-06-12 05:35:00
GAMMA Investing LLC Increases Stock Holdings in Natera, Inc. (NASDAQ:NTRA)
GAMMA Investing LLC boosted its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 18,607.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 119,916 shares of the medical research company’s stock after purchasing an additional 119,275 shares during the quarter. […] - 2025-06-06 05:48:57
Mackenzie Financial Corp Purchases 1,092 Shares of Natera, Inc. (NASDAQ:NTRA)
Mackenzie Financial Corp lifted its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 33.9% during the fourth quarter, HoldingsChannel reports. The firm owned 4,317 shares of the medical research company’s stock after buying an additional 1,092 shares during the quarter. Mackenzie Financial Corp’s holdings in Natera were worth $683,000 at the end […] - 2025-06-02 05:53:03
Notable ETF Outflow Detected - XBI, EXAS, NBIX, NTRA
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $257.5 million dollar outflow -- that's a 5.2% decrease week over week - 2025-05-30 14:40:38
Peek Under The Hood: ILCG Has 14% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-26 10:36:15
Quantinno Capital Management LP Takes $373,000 Position in Natera, Inc. (NASDAQ:NTRA)
Quantinno Capital Management LP bought a new position in Natera, Inc. (NASDAQ:NTRA – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 2,356 shares of the medical research company’s stock, valued at approximately $373,000. Other institutional investors also recently bought and sold shares of the company. […] - 2025-05-26 04:57:03
SPDR S&P Biotech ETF Experiences Big Outflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $140.8 million dollar outflow -- that's a 2.8% decrease week over week - 2025-05-22 11:55:21
Lazard Asset Management LLC Buys 551 Shares of Natera, Inc. (NASDAQ:NTRA)
Lazard Asset Management LLC raised its stake in Natera, Inc. (NASDAQ:NTRA – Free Report) by 22.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,052 shares of the medical research company’s stock after acquiring an additional 551 shares during the period. Lazard Asset […] - 2025-05-22 05:48:58
Focus Partners Wealth Purchases 1,442 Shares of Natera, Inc. (NASDAQ:NTRA)
Focus Partners Wealth raised its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 35.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,519 shares of the medical research company’s stock after purchasing an additional 1,442 shares during the period. […] - 2025-05-19 05:20:56
Cetera Investment Advisers Cuts Stake in Natera, Inc. (NASDAQ:NTRA)
Cetera Investment Advisers reduced its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 8.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 13,145 shares of the medical research company’s stock after selling 1,176 shares during the period. Cetera Investment Advisers’ holdings in Natera were worth […] - 2025-05-19 04:38:49

iShares Russell 2000 Swap UCITS ETF NTRA holdings

DateNumber of NTRA Shares HeldBase Market Value of NTRA SharesLocal Market Value of NTRA SharesChange in NTRA Shares HeldChange in NTRA Base ValueCurrent Price per NTRA Share HeldPrevious Price per NTRA Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NTRA by Blackrock for IE0007O06KL9

Show aggregate share trades of NTRA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-06-24BUY910171.870172.125 172.099USD 156,611 153.71
2025-06-23SELL-910170.370173.387 173.085USD -157,508 155.13 Loss of -16,342 on sale
2025-06-20BUY910171.860173.500 173.336USD 157,736 154.72
2025-06-19BUY910 170.980* 154.31
2025-06-18BUY910170.980172.730 172.555USD 157,025 153.88
2025-06-17BUY910167.550168.000 167.955USD 152,839 153.53
2025-06-16BUY910168.250169.169 169.077USD 153,860 153.13
2025-06-13BUY910165.340166.990 166.825USD 151,811 152.79
2025-06-12BUY910164.350166.440 166.231USD 151,270 152.46
2025-06-11BUY1,363166.760168.000 167.876USD 228,815 152.04
2025-06-10BUY1,816165.220166.590 166.453USD 302,279 151.64
2025-06-09BUY1,816164.190165.870 165.702USD 300,915 151.24
2025-06-06BUY1,816163.760169.930 169.313USD 307,472 150.84
2025-06-05BUY1,816165.510168.220 167.949USD 304,995 150.35
2025-06-04BUY1,816167.220169.430 169.209USD 307,284 149.77
2025-06-03BUY1,816160.150162.420 162.193USD 294,542 149.40
2025-06-02BUY1,816160.690160.900 160.879USD 292,156 148.98
2025-05-30BUY1,816157.730158.060 158.027USD 286,977 148.65
2025-05-29BUY1,816158.050165.910 165.124USD 299,865 148.27
2025-05-28BUY1,816161.210161.960 161.885USD 293,983 147.73
2025-05-27BUY1,816157.160158.380 158.258USD 287,397 147.32
2025-05-23BUY1,816153.320154.290 154.193USD 280,014 147.05
2025-05-22BUY1,816152.480154.090 153.929USD 279,535 146.79
2025-05-21BUY1,816151.090155.020 154.627USD 280,803 146.57
2025-05-20BUY1,816154.530154.795 154.768USD 281,060 146.15
2025-05-19BUY1,816153.270153.590 153.558USD 278,861 145.76
2025-05-16BUY1,816152.590153.400 153.319USD 278,427 145.36
2025-05-15BUY1,816149.400151.660 151.434USD 275,004 145.10
2025-05-14BUY1,816151.340154.693 154.358USD 280,314 144.69
2025-05-13BUY1,816152.280156.525 156.100USD 283,478 144.15
2025-05-12SELL-1,816157.290160.660 160.323USD -291,147 148.85 Loss of -20,831 on sale
2025-05-09BUY1,816151.950166.000 164.595USD 298,905 148.59
2025-05-08BUY1,816162.570163.800 163.677USD 297,237 147.32
2025-05-07BUY1,816160.100160.210 160.199USD 290,921 146.05
2025-05-06BUY1,816155.500158.446 158.151USD 287,203 145.00
2025-05-05BUY1,816157.380159.150 158.973USD 288,695 143.45
2025-05-02BUY1,816156.660158.530 158.343USD 287,551 141.56
2025-05-01BUY1,816151.360153.700 153.466USD 278,694 139.93
2025-04-30BUY1,816150.930152.520 152.361USD 276,688 137.73
2025-04-29BUY1,816154.890155.955 155.849USD 283,021 133.43
2025-04-28BUY1,816152.990155.440 155.195USD 281,834 126.92
2025-04-25BUY1,816153.790155.500 155.329USD 282,077 113.48
2025-04-24BUY1,816154.480154.560 154.552USD 280,666 72.48
2025-04-23SELL-1,816148.560153.490 152.997USD -277,843 0.00 Loss of -277,843 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NTRA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19126,2600232,63154.3%
2025-09-18144,24118274,55952.5%
2025-09-17102,8110191,09653.8%
2025-09-16163,3050322,09250.7%
2025-09-15156,6200366,93342.7%
2025-09-12158,712429293,33454.1%
2025-09-11158,8820296,49253.6%
2025-09-10196,055571488,41140.1%
2025-09-09295,3272,214529,76655.7%
2025-09-08127,8734,558341,37237.5%
2025-09-05139,247557240,08058.0%
2025-09-04114,9270340,92033.7%
2025-09-03132,14715431,80330.6%
2025-09-02128,238100366,75435.0%
2025-08-29153,2401285,28853.7%
2025-08-28174,2574,763367,92247.4%
2025-08-27145,7628294,09749.6%
2025-08-26208,7912,816345,67960.4%
2025-08-25266,388906451,97358.9%
2025-08-22175,2122,003308,50356.8%
2025-08-21170,741495291,58758.6%
2025-08-20203,3530572,80035.5%
2025-08-19170,7540361,90647.2%
2025-08-18256,114548697,79336.7%
2025-08-15279,8541,024482,55058.0%
2025-08-14118,4052,294220,43653.7%
2025-08-13163,1600412,23339.6%
2025-08-12407,38557745,52354.6%
2025-08-11345,127750727,13847.5%
2025-08-08698,2702,9291,441,31448.4%
2025-08-07859,77511,530,36456.2%
2025-08-06413,2250891,10046.4%
2025-08-05455,46779913,55949.9%
2025-08-04266,22059690,58438.5%
2025-08-01231,876153545,80642.5%
2025-07-31287,33241581,20149.4%
2025-07-30295,217111461,18364.0%
2025-07-29302,452295553,32954.7%
2025-07-28502,479154,335728,11569.0%
2025-07-25377,677280580,86665.0%
2025-07-24400,5231,264696,54857.5%
2025-07-23337,2771,015949,56135.5%
2025-07-22259,235270490,00552.9%
2025-07-21380,2442,771604,16362.9%
2025-07-18220,88811,544543,87340.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy